The SSRI Debate Flares Again
New federal guidelines for SSRIs and the battle for psychiatry’s future.
Posted June 2, 2026 | Reviewed by Michelle Quirk
On May 4, 2026, U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., laid out a series of new federal guidelines regarding selective serotonin reuptake inhibitors (SSRIs). There are four key pillars of these guidelines:
The proposals are striking for their modesty. There’s nothing particularly radical here. Many mental health professionals, in fact, have long pointed out that we do have alternatives to SSRIs. For example, a recent study showed that for mild to moderate depression, exercise is comparable, and sometimes superior , to SSRIs.
Yet, psychiatry’s reaction to these proposals was overwhelmingly one of rejection and even alarm.
A new national survey of psychiatrists , conducted at the May 2026 meeting of the American Psychiatric Association in San Francisco, found that:
The survey was undertaken partly in response to recent comments by former APA president Theresa Miskimen Rivera, which some psychiatrists viewed as too conciliatory.
What could explain the profession‑wide hostility to the HHS directives? To understand the intensity of the reaction, we must look to history.
A History of Psychiatry’s Identity Crisis
In the 1950s, psychiatry was in crisis. While major medical discoveries were being made in other fields, such as cardiology, oncology, and infectious disease, psychiatry had little to show for itself.
At the time, American psychiatry was split into two camps. There were the psychoanalysts, who tried to cure disorders from depression to schizophrenia by exploring the patient’s buried psychological conflicts. And there were the experimentalists—asylum doctors who used extreme methods such as insulin comas and lobotomies to manage unruly patients.
During the 1950s and '60s, psychiatry began turning to drugs: antipsychotics , antidepressants , and anti‑ anxiety medications. Yet these drugs often had debilitating side effects. Many early medications, like reserpine (an antipsychotic) and Marsilid (an antidepressant), were quickly pulled from the market because of those side effects.
As I explain in my book The Madness Pill , many doctors at the time—and much of the public—didn’t even consider psychiatry a fully legitimate branch of medicine. It was seen as unscientific and out of step with the rest of medical practice.
In the 1970s and '80s, a paradigm shift took place in psychiatry. Increasingly, the field came to see mental disorders as brain disorders to be managed with drugs. This shift was given expression in books like Nancy Andreasen’s The Broken Brain and Jon Franklin’s Molecules of the Mind . It was fully solidified by 1988 with the emergence of Prozac.
This shift also went hand in hand with a deepening relationship between psychiatry and pharmaceutical companies. By the 1990s, the public began to hear the now‑discredited message that depression is a “chemical imbalance” that can be corrected with drugs. Researchers began searching for the neurological and genetic basis of the dysfunctions that cause mental illness.
Psychiatry was finally starting to look like the rest of medicine.
With this history in mind, it’s easy to see why RFK Jr.’s recent guidelines have caused such a stir in the profession—and such sweeping rejection.
The Symbolic Power of SSRIs
What the history of psychiatry shows us is this: When you criticize SSRIs, you’re not just criticizing one particular treatment among others. You’re criticizing a status symbol.
SSRIs are a symbol of the emergence of psychiatry as a scientific discipline. They—and drugs more generally—are emblematic of the field’s claim to medical legitimacy. They are precisely what brought psychiatry from being medicine’s ugly stepchild to its crown prince.
Given this background, we shouldn’t expect calm, reasoned discussion about the new guidelines. The guidelines kicked the proverbial hornet’s nest, and it will take time for the field to respond thoughtfully.
Psychiatry today is at a crossroads. It can continue with business as usual, dispensing SSRIs and other psychiatric medications as a first‑line treatment for mental health problems. Or it can gradually move toward a whole‑person approach—one that emphasizes the four pillars of positive mental health: diet, exercise, sleep, and social connection. This whole‑person approach would not exclude drugs, but it would not treat them as the first line of defense against mild to moderate illness.
That choice will define psychiatry’s future for decades to come.
Parts of this essay were adapted from my recent book, The Madness Pill: One Doctor's Quest to Understand Schizophrenia (St. Martin's Press, 2026).
Share this post Facebook Bluesky Linkedin Email
There was a problem adding your email address. Please try again.
By submitting your information you agree to the Psychology Today Terms & Conditions and Privacy Policy
Justin Garson, Ph.D., is a philosopher and author of The Madness Pill: One Doctor’s Quest to Understand Schizophrenia (St. Martin’s Press, 2026) and Madness: A Philosophical Exploration (Oxford, 2022).
Get the help you need from a therapist near you–a FREE service from Psychology Today.
This article is part of the Bringwise Psychology Journal — daily insights on human behavior, mental health, and personal growth.